Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2007

View Archived Issues

Recent patents impart new therapeutic agents for cancer

Recent Bristol-Myers Squibb patent describes new agents for thrombotic disorders

Mechanism behind orlistat's antitumor activity explored

New compounds targeting autoimmune diseases claimed in recent Mitsubishi Pharma patent

pSivida reflects on transition to drug delivery company

Fast track designation for Generx

Enrollment open in women-only drug-eluting stent trial

TAK-491 enters phase III in U.S. and Europe

Antares Pharma and Jazz sign product development and license agreement

GeoVax begins two new AIDS vaccine clinical trials

Salix submits NDA for twice daily antiinflammatory balsalazide

Cortex to resume Alzheimer-PET scan study with higher dose levels

Roche and Trimeris begin integrase inhibitor and once-daily Fuzeon combination trial

Avastin recommended for E.U. approval in NSCLC

Celsentri recommended for approval in E.U.

Sugammadex MAA accepted for review

Galvus receives European recommendation for approval

CHMP recommends E.U. approval of Aclasta for postmenopausal osteoporosis

Exelon Patch recommended for E.U. approval

Yondelis recommended for E.U. approval in soft tissue sarcoma

EMEA recommends approval for Merz's Xeomin

LG Life Sciences synthesizes novel, potent DPP-IV inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...